Aldeyra Therapeutics
ALDX
ALDX
105 hedge funds and large institutions have $125M invested in Aldeyra Therapeutics in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 24 increasing their positions, 47 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
49% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 47
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less capital invested
Capital invested by funds: $252M → $125M (-$127M)
Holders
105
Holding in Top 10
1
Calls
$383K
Puts
$446K
Top Buyers
| 1 | +$8.58M | |
| 2 | +$4.48M | |
| 3 | +$2.6M | |
| 4 |
Morgan Stanley
New York
|
+$2.07M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.37M |
Top Sellers
| 1 | -$9.68M | |
| 2 | -$7.61M | |
| 3 | -$7.54M | |
| 4 |
Rafferty Asset Management
New York
|
-$1.79M |
| 5 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$869K |